
|Videos|July 27, 2015
The Lessons of High Cost Specialty Drug Product Launches
Author(s)Davy James, Managing Editor
David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, Inc, discusses takeaways from the impact of high cost drug launches on specialty pharmacy.
Advertisement
David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, Inc, discusses takeaways from the impact of high cost drug launches on specialty pharmacy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
NK3 as a Drug Target: From Scientific Discovery to Guideline-Recognized Therapy
2
Orforglipron Reduces Body Weight Up to 14% in Women at Every Stage of Menopause
3
New Evidence Positions Finerenone as Foundational Therapy Across the CKD Spectrum
4
OTC Guide: Thirty Years Strong
5






























































































































